Mohamed ZS, Wu Q, Jacome MA, Chen J, Etame AB (2025) The Role of Gut Microbiome on Glioblastoma Oncogenesis and Malignant Evolution. Int J Mol Sci 26. https://doi.org/10.3390/ijms26072935

Rong L, Li N, Zhang Z (2022) Emerging therapies for glioblastoma: current state and future directions. J Experimental Clin Cancer Res 41. https://doi.org/10.1186/s13046-022-02349-7

Zhang X, Zhao L, Zhang H, Zhang Y, Ju H, Wang X et al (2022) The immunosuppressive microenvironment and immunotherapy in human glioblastoma. Front Immunol 13. https://doi.org/10.3389/fimmu.2022.1003651

Kiran NS, Yashaswini C, Chatterjee A, Prajapati B (2025) Impact of gastrointestinal dysbiosis on tryptophan metabolism and neurological cancer progression. Med Oncol 42:412. https://doi.org/10.1007/s12032-025-02972-2

Article  CAS  PubMed  Google Scholar 

Lin B, Ye Z, Ye Z, Wang M, Cao Z, Gao R et al (2023) Gut microbiota in brain tumors: An emerging crucial player. CNS Neurosci Ther 29:84–97. https://doi.org/10.1111/cns.14081

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rutsch A, Kantsjö JB, Ronchi F (2020) The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology. Front Immunol 11. https://doi.org/10.3389/fimmu.2020.604179

Wang HX, Wang YP (2016) Gut microbiota-brain axis. Chin Med J (Engl) 129:2373–2380. https://doi.org/10.4103/0366-6999.190667

Article  PubMed  PubMed Central  Google Scholar 

Liu CG, Lin MX, Xin Y, Sun M, Cui J, Liu D et al (2025) Metagenomics and non-targeted metabolomics reveal the role of gut microbiota and its metabolites in brain metastasis of non-small cell lung cancer. Thorac Cancer 16. https://doi.org/10.1111/1759-7714.70068

Zhao LY, Mei JX, Yu G, Lei L, Zhang WH, Liu K et al (2023) Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications. Signal Transduct Target Ther 8. https://doi.org/10.1038/s41392-023-01406-7

Kumar Yadav M, Kumari I, Singh B, Kant Sharma K, Kumar Tiwari S (n.d.) MINI-REVIEW Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics. https://doi.org/10.1007/s00253-021-11646-8/Published

Delphan M, Delfan N, West DWD, Delfan M (2022) Exercise protocols: The gap between preclinical and clinical exercise oncology studies. Metabol Open 13:100165. https://doi.org/10.1016/j.metop.2022.100165

Article  PubMed  PubMed Central  Google Scholar 

Jiang M, Zhang X, Zhang Y, Liu Y, Geng R, Liu H et al (2023) The Effects of Perioperative Probiotics on Postoperative Gastrointestinal Function in Patients with Brain Tumors: A Randomized, Placebo-Controlled Study. Nutr Cancer 75:1132–1142. https://doi.org/10.1080/01635581.2023.2178929

Article  PubMed  Google Scholar 

Bajaj JS, Shamsaddini A, Fagan A, McGeorge S, Gavis E, Sikaroodi M et al (2021) Distinct gut microbial compositional and functional changes associated with impaired inhibitory control in patients with cirrhosis. Gut Microbes 13. https://doi.org/10.1080/19490976.2021.1953247

Zeng C, Zhang C, He C, Song H (2023) Investigating the causal impact of gut microbiota on glioblastoma: a bidirectional Mendelian randomization study. BMC Genomics 24. https://doi.org/10.1186/s12864-023-09885-2

Liu C, Liu F, Nie D, Xiao Y, Wu W, Jia Y et al (2024) Gut microbiota composition and metabolic characteristics in patients with Craniopharyngioma. BMC Cancer 24. https://doi.org/10.1186/s12885-024-12283-w

Dossena C, Bergamaschi L, Rossignoli F, Licata AG, Gasparini P, Venturini LV et al (2025) Distinct gut microbiota composition in pediatric patients with central nervous system (CNS) tumors: a comparative study. Neurooncol Adv 7. https://doi.org/10.1093/noajnl/vdaf042

Morten KJ, Staines-Urias E, Kenyon J (2018) Potential clinical usefulness of gut microbiome testing in a variety of clinical conditions. Hum Microb J 10:6–10. https://doi.org/10.1016/j.humic.2018.08.003

Article  Google Scholar 

Weathers SP, Li X, Zhu H, Damania AV, Knafl M, McKinley B et al (2025) Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I/II trial. Nat Commun 16. https://doi.org/10.1038/s41467-025-56930-7

Hu J, Yang J, Chen L, Meng X, Zhang X, Li W et al (2022) Alterations of the gut microbiome in patients with pituitary adenoma. Pathol Oncol Res 28. https://doi.org/10.3389/pore.2022.1610402

Huang J-H, Wang J, Chai X-Q, Li Z-C, Jiang Y-H, Li J et al (2022) The intratumoral bacterial metataxonomic signature of hepatocellular carcinoma. Microbiol Spectr 10. https://doi.org/10.1128/spectrum.00983-22

Ishaq HM, Yasin R, Mohammad IS, Fan Y, Li H, Shahzad M et al (2024) The gut-brain-axis: a positive relationship between gut microbial dysbiosis and glioblastoma brain tumour. Heliyon 10. https://doi.org/10.1016/j.heliyon.2024.e30494

Jiang H, Zeng W, Zhang X, Pei Y, Zhang H, Li Y (2022) The role of gut microbiota in patients with benign and malignant brain tumors: a pilot study. Bioengineered 13:7847–7859. https://doi.org/10.1080/21655979.2022.2049959

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Jiang H, Wang X, Liu X, Huang Y, Wang Z et al (2022) Crosstalk between the gut and brain: importance of the fecal microbiota in patient with brain tumors. Front Cell Infect Microbiol 12. https://doi.org/10.3389/fcimb.2022.881071

Li Z, Zhao K, Liu H, Liu J, Chen X, Hu W et al (2025) Construction of predictive machine learning model of glioma-associated gut microbiota. Brain Behav 15. https://doi.org/10.1002/brb3.70843

Liang F, Sun Y, Yang J, Shen Z, Wang G, Zhu J et al (2025) Gut microbiome is associated with radiotherapy response in lung cancer patients with brain metastases. Front Cell Infect Microbiol 15. https://doi.org/10.3389/fcimb.2025.1562831

Polster SP, Sharma A, Tanes C, Tang AT, Mericko P, Cao Y et al (2020) Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angioma. Nat Commun 11. https://doi.org/10.1038/s41467-020-16436-w

Yang J, Wei H, Lin Y, Chu ESH, Zhou Y, Gou H et al (2024) High Soluble Fiber Promotes Colorectal Tumorigenesis Through Modulating Gut Microbiota and Metabolites in Mice. Gastroenterology 166(7):323–337e. https://doi.org/10.1053/j.gastro.2023.10.012

Article  CAS  PubMed  Google Scholar 

Keane L, Cryan JF, Gleeson JP (2025) Exploiting the gut microbiome for brain tumour treatment. Trends Mol Med 31:213–223. https://doi.org/10.1016/j.molmed.2024.08.008

Article  CAS  PubMed  Google Scholar 

Wang W, Liu M, Wang Z, Ye W, Li X (2025) Causal relationship between gut microbiota and pituitary neuroendocrine tumors: a bidirectional Mendelian randomization. Discover Oncol 16. https://doi.org/10.1007/s12672-025-02958-6

Shen Y, Fan N, Ma S, xia, Cheng X, Yang X, Wang G (2025) Gut microbiota dysbiosis: pathogenesis, diseases, prevention, and therapy. MedComm (Beijing) 6. https://doi.org/10.1002/mco2.70168

Leigh J, Skidmore B, Wong A, Maleki Vareki S, Ng TL (2025) Exploring the microbiome’s impact on glioma and brain metastases: insights into development, progression, and treatment response—A. Scoping Rev Cancers (Basel) 17. https://doi.org/10.3390/cancers17071228

Nowacka A, Śniegocki M, Bożiłow D, Ziółkowska E (2025) Gut Microbiota and central nervous system tumors: a comprehensive systematic review and meta-analysis of microbiome-CNS interactions. Int J Mol Sci 26. https://doi.org/10.3390/ijms262110721